
The FDA Reconsiders Its Warnings on Hormone Therapy in Menopause: The Beginning of a New Era for Women’s Health?
The combination of bioidentical estradiol and micronized progesterone has shown, according to scientific literature, no association with thrombotic events or an increased risk of breast









